Stay updated with breaking news from Daptorum group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptorum Group Limited , a clinical-stage biopharmaceutical company, announced that it has received an approval letter from the Nasdaq Stock Market LLC Listing Qualifications Department notifying. -Today at 02:58 am- MarketScreener ....
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 8,800 shares, a drop of 33.8% from the June 30th total of 13,300 shares. Based on an average daily trading volume, of 310,600 […] ....
Aptorum Group Limited: Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Global Genomics Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com s offering. The Global. ....
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that the group has submitted t. ....